Bifidobacterium bacteraemia is rare with routine probiotics use in preterm infants: A further case report with literature review

Antia Acuna-Gonzalez; Magdalena Kujawska; Mayada Youssif; Thomas Atkinson; Sara Grundy; Alexandra Hutchison; Catherine Tremlett; Paul Clarke; Lindsay J. Hall

doi:10.1016/j.anaerobe.2023.102713

Bifidobacterium bacteraemia is rare with routine probiotics use in preterm infants: A further case report with literature review

Antia Acuna-Gonzalez, Magdalena Kujawska, Mayada Youssif, Thomas Atkinson, Sara Grundy, Alexandra Hutchison, Catherine Tremlett, Paul Clarke^*, Lindsay J. Hall^*

^*Corresponding author for this work

Microbiology and Infection

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

39 Downloads (Pure)

Abstract

Prophylactic administration of oral probiotics is associated with significant reductions in the morbidity and mortality of necrotising enterocolitis in preterm infants. We document the first case of Bifidobacterium longum subsp. infantis sub-clinical bacteraemia, in an extremely low birth weight preterm infant, since introduction of routine probiotic treatment at the Norfolk and Norwich University Hospital 10 years ago. Whole genome comparisons confirmed the isolated strain likely originated from the probiotic product.

Original language	English
Article number	102713
Number of pages	5
Journal	Anaerobe
Volume	80
Early online date	6 Feb 2023
DOIs	https://doi.org/10.1016/j.anaerobe.2023.102713
Publication status	Published - Apr 2023

Bibliographical note

Funding Information:
L.J.H. is supported by Wellcome Trust Investigator Awards 100974/C/13/Z and 220876/Z/20/Z ; the Biotechnology and Biological Sciences Research Council (BBSRC), Institute Strategic Programme Gut Microbes and Health BB/R012490/1 , and its constituent projects BBS/E/F/000PR10353 and BBS/E/F/000PR10356 .

Publisher Copyright:
© 2023 The Authors

ASJC Scopus subject areas

Microbiology
Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.anaerobe.2023.102713Licence: Creative Commons: Attribution (CC BY)

AcunaGonzalezAFinal published version, 0.98 MBLicence: Creative Commons: Attribution (CC BY)

Cite this

@article{59c930deb457419e8572e94781563475,

title = "Bifidobacterium bacteraemia is rare with routine probiotics use in preterm infants: A further case report with literature review",

abstract = "Prophylactic administration of oral probiotics is associated with significant reductions in the morbidity and mortality of necrotising enterocolitis in preterm infants. We document the first case of Bifidobacterium longum subsp. infantis sub-clinical bacteraemia, in an extremely low birth weight preterm infant, since introduction of routine probiotic treatment at the Norfolk and Norwich University Hospital 10 years ago. Whole genome comparisons confirmed the isolated strain likely originated from the probiotic product.",

author = "Antia Acuna-Gonzalez and Magdalena Kujawska and Mayada Youssif and Thomas Atkinson and Sara Grundy and Alexandra Hutchison and Catherine Tremlett and Paul Clarke and Hall, {Lindsay J.}",

note = "Funding Information: L.J.H. is supported by Wellcome Trust Investigator Awards 100974/C/13/Z and 220876/Z/20/Z ; the Biotechnology and Biological Sciences Research Council (BBSRC), Institute Strategic Programme Gut Microbes and Health BB/R012490/1 , and its constituent projects BBS/E/F/000PR10353 and BBS/E/F/000PR10356 . Publisher Copyright: {\textcopyright} 2023 The Authors",

year = "2023",

month = apr,

doi = "10.1016/j.anaerobe.2023.102713",

language = "English",

volume = "80",

journal = "Anaerobe",

issn = "1075-9964",

publisher = "Elsevier",

}

TY - JOUR

T1 - Bifidobacterium bacteraemia is rare with routine probiotics use in preterm infants

T2 - A further case report with literature review

AU - Acuna-Gonzalez, Antia

AU - Kujawska, Magdalena

AU - Youssif, Mayada

AU - Atkinson, Thomas

AU - Grundy, Sara

AU - Hutchison, Alexandra

AU - Tremlett, Catherine

AU - Clarke, Paul

AU - Hall, Lindsay J.

N1 - Funding Information: L.J.H. is supported by Wellcome Trust Investigator Awards 100974/C/13/Z and 220876/Z/20/Z ; the Biotechnology and Biological Sciences Research Council (BBSRC), Institute Strategic Programme Gut Microbes and Health BB/R012490/1 , and its constituent projects BBS/E/F/000PR10353 and BBS/E/F/000PR10356 . Publisher Copyright: © 2023 The Authors

PY - 2023/4

Y1 - 2023/4

N2 - Prophylactic administration of oral probiotics is associated with significant reductions in the morbidity and mortality of necrotising enterocolitis in preterm infants. We document the first case of Bifidobacterium longum subsp. infantis sub-clinical bacteraemia, in an extremely low birth weight preterm infant, since introduction of routine probiotic treatment at the Norfolk and Norwich University Hospital 10 years ago. Whole genome comparisons confirmed the isolated strain likely originated from the probiotic product.

AB - Prophylactic administration of oral probiotics is associated with significant reductions in the morbidity and mortality of necrotising enterocolitis in preterm infants. We document the first case of Bifidobacterium longum subsp. infantis sub-clinical bacteraemia, in an extremely low birth weight preterm infant, since introduction of routine probiotic treatment at the Norfolk and Norwich University Hospital 10 years ago. Whole genome comparisons confirmed the isolated strain likely originated from the probiotic product.

UR - http://www.scopus.com/inward/record.url?scp=85147860379&partnerID=8YFLogxK

U2 - 10.1016/j.anaerobe.2023.102713

DO - 10.1016/j.anaerobe.2023.102713

M3 - Article

C2 - 36754140

AN - SCOPUS:85147860379

SN - 1075-9964

VL - 80

JO - Anaerobe

JF - Anaerobe

M1 - 102713

ER -

Bifidobacterium bacteraemia is rare with routine probiotics use in preterm infants: A further case report with literature review

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Cite this